✦ LIBER ✦

Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation

✍ Scribed by Coyle, Doug; Coyle, Kathryn; Cameron, Chris; Lee, Karen; Kelly, Shannon; Steiner, Sabine; Wells, George A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stroke prevention in patients with atria

✍ Lanitis, T.; Cotté, F. E.; Gaudin, A. F.; Kachaner, I.; Kongnakorn, T.; Durand-Z 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 611 KB

Cost-effectiveness of new oral anticoagu

✍ Kansal, Anuraag R.; Zheng, Ying; Pokora, Tiffany; Sorensen, Sonja V. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Cost-Effectiveness of Apixaban Versus Ot

✍ Lip, Gregory Y.H.; Kongnakorn, Thitima; Phatak, Hemant; Kuznik, Andreas; Lanitis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 904 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

New Anticoagulants for Prevention of Str

✍ JUAN F. VILES-GONZALEZ; VALENTIN FUSTER; JONATHAN L. HALPERIN 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

Controversies regarding the new oral ant

✍ Mohanty, B. D.; Looser, P. M.; Gokanapudy, L. R.; Handa, R.; Mohanty, S.; Choi, 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 617 KB